Effects of triptolide from Tripterygium wilfordii on ERα and p53 expression in two human breast cancer cell lines

Phytomedicine

Volumn 16, Issue 11, 2009, Pages 1006-1013

  Liu, Jing ^a   Jiang, Zhenzhou ^a   Xiao, Jingwei ^a,b   Zhang, Yun ^a   Lin, Sensen ^a   Duan, Weigang ^b   Yao, Jincheng ^a   Liu, Chunhui ^a   Huang, Xin ^a   Wang, Tao ^a   Liang, Zhongliang ^a   Wang, Rongrong ^a   Zhang, Shuang ^a   Zhang, Luyong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Estrogen receptor alpha; Human breast cancer cells; P53; Tripterygium wilfordii; Triptolide

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROTEIN P53; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; WILD TYPE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS SHAPE; CELL PROLIFERATION; DITERPENES; EPOXY COMPOUNDS; ESTROGEN RECEPTOR ALPHA; FLOW CYTOMETRY; HUMANS; PHENANTHRENES; PLANT EXTRACTS; TRIPTERYGIUM; TUMOR SUPPRESSOR PROTEIN P53;

TRIPTERYGIUM WILFORDII;

EID: 70349768102     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.03.021     Document Type: Article

References (35)

1. Ali S., and Coombes R.C. Estrogen receptor alpha in human breast cancer: occurrence and significance. Journal of Mammary Gland Biology and Neoplasia 5 (2000) 271-281
2. Arathi R., Setty M.D., Leonard H., and Sigal M.D. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism 6 (2005) 773-784
3. Cadwell C., and Zambetti G.P. The effects of wild-type P53 tumor suppressor activity and mutant P53 gain-of-function on cell growth. Gene 277 (2001) 15-30
4. Chang W.T., Kang J.J., Lee K.Y., Wei K., Anderson E., Gotmare S., Ross J.A., and Rosen G.D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the P53 pathway. The Journal of Biological Chemistry 276 (2001) 2221-2227
5. Chen B.J. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leukemia & lymphoma 3 (2001) 253-265
6. Clarke R., Leonessa F., and Trock B. Multidrug resistance/Pglycoprotein and breast cancer: review and meta-analysis. Seminars in Oncology 32 (2005) S9-S15
7. Cui D., Hoshii Y., Kawano H., Sugiyama S., Gondo T., Liu Y., and Ishihara T. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine. International Immunopharmacology 7 (2007) 1232-1240
8. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 245-248
9. Fidler J.M., Li K., Chung C., Wei K., Ross J.A., Gao M., and Rosen G.D. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Molecular Cancer Therapeutics 2 (2003) 855-862
10. Greenlee R.T., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA: A Cancer Journal for Clinicians 50 (2000) 7-33
11. Gustafsson J.A., and Warner M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 74 (2000) 245-248
12. Jensen E.V., and Jordan V.C. The estrogen receptor: a model for molecular medicine. Clinical Cancer Research 9 (2003) 1980-1989
13. Jiang X.H., Wong B.C., Lin M.C., Zhu G.H., Kung H.F., Jiang S.H., Yang D., and Lam S.K. Functional P53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-jB activation in gastric cancer cells. Oncogene 20 (2001) 8009-8018
14. Jordan V.C., and Brodie A.M.H. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 72 (2007) 7-25
15. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clinical Cancer Research 8 (2002) 2666-2674
16. Lin J., Chen L., Lin Z., and Zhao M. The inhibitory effect of triptolide on Glioblastoma multiforme in vitro. The Journal of International Medical Research 35 (2007) 490-496
17. Lipsky P.E., and Tao X.L. A potential new treatment for rheumatoid arthritis: thunder god vine. Seminars in Arthritis and Rheumatism 5 (1997) 713-723
18. Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., and Cao X. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochemical and Biophysical Research Communications 345 (2006) 1122-1130
19. Lou Y.J., Jin J., and Wang Y.G. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leukemia Research 29 (2005) 99-105
20. Margueron R., Duong V., Castet A., and Cavailles V. Histone deacetylase inhibition and estrogen signaling in human breast cancer cells. Biochemical Pharmacology 68 (2004) 1239-1246
21. McDonnell D.P., and Norris J.D. Connections and regulation of the human estrogen receptor. Science 296 (2002) 1642-1644
22. 2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells. Biochemical and Biophysical Research Communications 336 (2005) 1081-1086
23. Palmieri C., Cheng G.J., Saji S., Zelada-Hedman M., Warri A., Weihua Z., Van Noorden S., Wahlstrom T., Coombes R.C., Warner M., and Gustafsson J.A. Estrogen receptor beta in breast cancer. Endocrine-Related Cancer 9 (2002) 1-13
24. Panichakul T., Intachote P., Wongkajorsilp A., Sripa B., and Sirisinha S. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis. Anticancer Research 26 (2006) 259-265
25. Paolo A., Alessio B., and Maria M. Structure-function relationship of estrogen receptor a and b: Impact on human health. Molecular Aspects of Medicine 27 (2006) 299-402
26. Park W.C., and Jordan V.C. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends in Molecular Medicine 8 (2002) 82-88
27. Qiu D., and Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs in R&D 4 (2003) 1-18
28. Shagufta, Srivastava A.K., Sharma R., Mishra R., Balapure A.K., Murthy P.S., and Panda G. Substituted phenanthrenes with basic amino side chains: a new series of anti-breast cancer agents. Bioorganic & Medicinal Chemistry 14 (2006) 1497-1505
29. Tao X.L., Younger J., Fan F.Z., Wang B., and Lipsky P.E. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis & Rheumatism 46 (2002) 1735-1743
30. Tong X., Zheng S., Jin J., Zhu L., Lou Y., and Yao H. Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells. Acta Biochimica et Biophysica Sinica 39 (2007) 89-95
31. Wang S.J., Zeng Y., and Yang Y.J. Experimental study of triptolide only or combined with cinobufotalin on MCF-7 growth of breast cancer. Modern Journal of Integrated Traditional Chinese and Western Medicine 15 (2006) 573-574
32. Wang W.J. Analysis of forward curative effects of 88 cases of breast cancer treated by halsted's radical operation. Journal of Linyi Medical school 10 (1988) 141-144
33. Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., and Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Molecular Cancer Therapeutics 2 (2003) 65-72
34. Yao J.C., Jiang Z.Z., Duan W.G., Huang J.F., Zhang L.Y., Hu L., He L., Li F., Xiao Y.J., Shu B., and Liu C.H. Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells. Biological & Pharmaceutical Bulletin 31 (2008) 592-597
35. Zhang R., Zhang P.Y., Guo J., Yang D., Wang W.J., Zheng M.H., and Ma Y.C. Effects of triptolide on prostate carcinoma in mouse RM-1 cells. Zhonghua Nan Ke Xue 13 (2007) 237-241